BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 360247)

  • 1. Prediction of response to chlordiazepoxide and placebo in anxious outpatients: an attempt at replication.
    Downing RW; Rickels K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):207-19. PubMed ID: 360247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being.
    Kellner R; Rada RT; Andersen T; Pathak D
    Psychopharmacology (Berl); 1979 Aug; 64(2):185-91. PubMed ID: 115039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loxapine in neurotic anxiety: some modifiers of treatment response.
    Rickels K; Weise CC; Feldman H; Fee EA; Wiswesser G
    J Int Med Res; 1978; 6(3):180-5. PubMed ID: 348533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of prochlorperazine, chlordiazepoxide and placebo in psychoneurotic outpatients with dominant symptoms of anxiety.
    Goldberg HL; Finnerty RJ
    Int Pharmacopsychiatry; 1979; 14(5):264-77. PubMed ID: 395128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician prognosis in relationship to drug and placebo response in anxious and depressed psychiatric outpatients.
    Downing RW; Rickels K
    J Nerv Ment Dis; 1983 Mar; 171(3):182-5. PubMed ID: 6338155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of loxapine succinate, librium, and placebo in neurotic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):8-12. PubMed ID: 4631381
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients: expected and unexpected findings--comparing doxepin, chlordiazepoxide and placebo.
    Goldstein BJ; Brauzer B; Steinbook RM; Jacobson AF
    South Med J; 1973 Aug; 66(8):892-7. PubMed ID: 4578609
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
    Kahn RJ; McNair DM; Lipman RS; Covi L; Rickels K; Downing R; Fisher S; Frankenthaler LM
    Arch Gen Psychiatry; 1986 Jan; 43(1):79-85. PubMed ID: 3510602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molindone and chlordiazepoxide in anxious neurotic outpatients.
    Rickels K; Hutchison J; Morris RJ; Csanalosi I; Parsia K; Pereira-Ogan JA
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):1-9. PubMed ID: 4621560
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety.
    Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
    Kingstone E; Villeneuve A; Kossatz I
    Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimozide versus chlordiazepoxide in anxiety neurosis.
    Doongaji DR; Sheth AS; Apte JS; Bharucha MP; Mundra VM; Ramesh S
    Acta Psychiatr Belg; 1981; 81(4):416-23. PubMed ID: 7036658
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic indicators of 4-week clinical improvement with chlordiazepoxide and hydroxyzine in anxious neurotic outpatients.
    Rickels K; Csanalosi I; Downing RW; Hesbacher PT
    Int Pharmacopsychiatry; 1971; 6(4):249-53. PubMed ID: 4950567
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyzine and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study.
    Rickels K; Gordon PE; Zamostien BB; Case W; Hutchison J; Chung H
    Compr Psychiatry; 1970 Sep; 11(5):457-74. PubMed ID: 4918308
    [No Abstract]   [Full Text] [Related]  

  • 16. Doctor-patient concordance in a placebo-controlled trial of limbitrol versus its components [proceedings].
    Jacobson AF
    Psychopharmacol Bull; 1978 Jul; 14(3):61-3. PubMed ID: 353872
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimensions of symptom distress in anxious neurotic outpatients.
    Mattsson NB; Williams HV; Rickels K; Lipman RS; Uhlenhuth EH
    Psychopharmacol Bull; 1969 Jan; 5(1):19-32. PubMed ID: 5797008
    [No Abstract]   [Full Text] [Related]  

  • 18. A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness.
    Feighner JP; Brauzer B; Gelenberg AJ; Gomez E; Kiev A; Kurland ML; Weiss BL
    Psychopharmacology (Berl); 1979 Mar; 61(2):217-25. PubMed ID: 108739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific factors and side effect complaints. Factors affecting the incidence of drowsiness in drug and placebo treated anxious and depressed outpatients.
    Downing RW; Rickels K; Rickels LA; Downing D
    Acta Psychiatr Scand; 1979 Nov; 60(5):438-48. PubMed ID: 395826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzoctamine and chlordiazepoxide in anxious outpatients: a collaborative study.
    Rickels K; Gratch MI; Gray BM; Laquer KG; Parish LC; Rosenfeld H; Whalen EM
    Dis Nerv Syst; 1972 Aug; 33(8):512-22. PubMed ID: 4678760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.